Study: Ketorolac Shows Good Short-Term Efficacy For Vitrectomy Patients

Wednesday, September 24, 2008

Comments

Ocular Surgery News

Topical ketorolac appears promising for reducing postoperative pain and inflammation and improving visual recovery after vitreoretinal surgery, a prospective study suggests.

Full Story

Retina Products and Equipment »

Which of the following treatments is FDA approved for the treatment of postoperative pseudophakic cystoid macular edema (Irvine-Gass syndrome)?
1. Topical prednisolone acetate 1% (PredForte) QID
2. Topical ketorolac tromethamine (Acular) QID
3. Topical nepefanac (Nevanac) TID
4. Intravitreal triamcinolone acetonide(Kenalog) in 0.1 cc
5. None of the above
Check The Answer

OPMI LUMERA 700 Surgical Microscope
OPMI LUMERA 700 Incorporating the latest... view product
Selecta Trio™ YAG Laser, SLT and Photocoagulation
The Lumenis Selecta® Trio™ ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Study: Ketorolac Shows Good Short-Term Efficacy For Vitrectomy Patients

Comments

Related Categories

Retina Products and Equipment »

Quick Quiz

Which of the following treatments is FDA approved for the treatment of postoperative pseudophakic cystoid macular edema (Irvine-Gass syndrome)?

AdGlare RMR Ad

Featured Products

OPMI LUMERA 700 Surgical Microscope

Selecta Trio™ YAG Laser, SLT and Photocoagulation

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us